https://www.selleckchem.com/pr....oducts/Deforolimus.h
3-7, p 0.01 and OR 13.3, 95% CI 7.8-22.7, p 0.01, respectively). Receiver operating characteristic curve analysis showed better risk stratification of the R CHA DS -VASc compared with both CHADS and CHA DS VASC score. The R CHA DS -VASc score is a better predictor of short- and long-term cardiovascular morbidity and mortality after hospital discharge. The R2CHA2DS2-VASc score is a better predictor of short- and long-term cardiovascular morbidity and mortality after hospital discharge.International trends currently favour g
Like
Comment
Share
